Platton Sean, McCormick Áine, Bukht Musfira, Gurney David, Holding Ian, Moore Gary W
The Royal London Hospital Haemophilia Centre Barts Health NHS Trust The Royal London Hospital London UK.
Haemostasis and Thrombosis Viapath Analytics St Thomas' Hospital London UK.
Res Pract Thromb Haemost. 2018 Aug 30;2(4):778-789. doi: 10.1002/rth2.12140. eCollection 2018 Oct.
Investigations of platelet function by light transmission aggregometry (LTA) using a dedicated aggregometer is time consuming and labor intensive. This multicenter study evaluated an automated LTA method using a coagulation analyzer to establish reference ranges and ideal testing regimen.
Sysmex CS-2x00 series analyzers were used to measure aggregation using a range of agonists and concentrations: ADP (1-20 μM); arachidonic acid (0.5-1.5 mM); collagen (1.25-5 μg/mL); ristocetin (0.5-1.5 g/L); epinephrine (5-10 μM); TRAP (1-20 μM); U46619 (1 μM); and saline. Maximum and final aggregation, disaggregation, slope, and acquisition time were compared for each.
For 42 normal subjects there was no significant difference in aggregation parameters for: 10 μM and 20 μm ADP; 2 and 2.5 μM ADP; 1 and 1.5 mM arachidonic acid; 2.5 and 5 μg/mL collagen; 1 and 1.25 μg/mL collagen; 1.25 and 1.5 g/L ristocetin; 5 and 10 μM epinephrine; 5 and 10 μM or 20 μM TRAP. Maximum aggregation was reached by 300 seconds with 20 and 10 μM ADP, 1 μM U46619, 1 and 1.25 μg/mL collagen, 1.5 g/L ristocetin and 5, 10, and 20 μM TRAP: all others agonists required 600s.
A standard panel of agonists can be used on the Sysmex CS-2x00 series analyzers: ADP (10, 5, 2.5, and 1.25 μM); 1 mM arachidonic acid; 1 μM U46619; 2.5 and 1.25 μg/mL collagen; 1.25 and 0.5 g/L ristocetin; 5 μM epinephrine; 5 and 10 μM TRAP; and saline. Aggregation should be observed for 600 seconds for all agonists except TRAP and U46619, which require 300 seconds. If further studies confirm these concentrations detect platelet disorders then Sysmex CS-series analyzers could replace dedicated aggregometers, or perform LTA where it is currently not available.
使用专用凝集仪通过光透射比浊法(LTA)检测血小板功能既耗时又费力。这项多中心研究评估了一种使用凝血分析仪的自动化LTA方法,以建立参考范围和理想的检测方案。
使用Sysmex CS - 2x00系列分析仪,采用一系列激动剂和浓度来测量凝集:二磷酸腺苷(ADP,1 - 20 μM);花生四烯酸(0.5 - 1.5 mM);胶原蛋白(1.25 - 5 μg/mL);瑞斯托霉素(0.5 - 1.5 g/L);肾上腺素(5 - 10 μM);凝血酶受体激活肽(TRAP,1 - 20 μM);U46619(1 μM);以及生理盐水。对每种情况的最大和最终凝集、解聚、斜率和采集时间进行了比较。
对于42名正常受试者,以下凝集参数无显著差异:10 μM和20 μM ADP;2 μM和2.5 μM ADP;1 mM和1.5 mM花生四烯酸;2.5 μg/mL和5 μg/mL胶原蛋白;1 μg/mL和1.25 μg/mL胶原蛋白;1.25 g/L和1.5 g/L瑞斯托霉素;5 μM和10 μM肾上腺素;5 μM、10 μM或20 μM TRAP。20 μM和10 μM ADP、1 μM U46619、1 μg/mL和1.25 μg/mL胶原蛋白、1.5 g/L瑞斯托霉素以及5 μM、10 μM和20 μM TRAP在300秒时达到最大凝集:所有其他激动剂需要600秒。
可在Sysmex CS - 2x00系列分析仪上使用一组标准激动剂:ADP(10 μM、5 μM、2.5 μM和1.25 μM);1 mM花生四烯酸;1 μM U46619;2.5 μg/mL和1.25 μg/mL胶原蛋白;1.25 g/L和0.5 g/L瑞斯托霉素;5 μM肾上腺素;5 μM和10 μM TRAP;以及生理盐水。除TRAP和U46619需要300秒外,所有激动剂的凝集均应观察600秒。如果进一步研究证实这些浓度能检测出血小板疾病,那么Sysmex CS系列分析仪可替代专用凝集仪,或在目前无法进行LTA检测的地方开展LTA检测。